- Home
- SABS vs SMTK Comparison
SABS vs SMTK Comparison
Compare SABS & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- SMTK
- Stock Information
- Founded
- SABS 2014
- SMTK 2009
- Country
- SABS United States
- SMTK United Kingdom
- Employees
- SABS N/A
- SMTK N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- SMTK
- Sector
- SABS Health Care
- SMTK
- Exchange
- SABS Nasdaq
- SMTK NYSE
- Market Cap
- SABS 11.4M
- SMTK 13.3M
- IPO Year
- SABS N/A
- SMTK N/A
- Fundamental
- Price
- SABS $1.75
- SMTK $2.31
- Analyst Decision
- SABS Strong Buy
- SMTK
- Analyst Count
- SABS 5
- SMTK 0
- Target Price
- SABS $11.40
- SMTK N/A
- AVG Volume (30 Days)
- SABS 25.4K
- SMTK 55.7K
- Earning Date
- SABS 05-19-2025
- SMTK 05-12-2025
- Dividend Yield
- SABS N/A
- SMTK N/A
- EPS Growth
- SABS N/A
- SMTK N/A
- EPS
- SABS N/A
- SMTK N/A
- Revenue
- SABS $1,322,410.00
- SMTK $82,000.00
- Revenue This Year
- SABS N/A
- SMTK N/A
- Revenue Next Year
- SABS $50.00
- SMTK N/A
- P/E Ratio
- SABS N/A
- SMTK N/A
- Revenue Growth
- SABS N/A
- SMTK 203.70
- 52 Week Low
- SABS $1.00
- SMTK $2.01
- 52 Week High
- SABS $5.01
- SMTK $13.00
- Technical
- Relative Strength Index (RSI)
- SABS 63.35
- SMTK N/A
- Support Level
- SABS $1.30
- SMTK N/A
- Resistance Level
- SABS $1.49
- SMTK N/A
- Average True Range (ATR)
- SABS 0.14
- SMTK 0.00
- MACD
- SABS 0.06
- SMTK 0.00
- Stochastic Oscillator
- SABS 100.00
- SMTK 0.00
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.